 | • レポートコード：MRC2-11QY04164 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は爪囲炎治療薬のグローバル市場について調査・分析したレポートです。種類別（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン、その他）市場規模、用途別（病院、診療所、皮膚科センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別爪囲炎治療薬の競争状況、市場シェア ・世界の爪囲炎治療薬市場：種類別市場規模 2015年-2020年（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン、その他） ・世界の爪囲炎治療薬市場：種類別市場規模予測 2021年-2026年（ムピロシン軟膏、フシジン酸軟膏、ゲンタマイシン軟膏、ジクロキサシリン、その他） ・世界の爪囲炎治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、皮膚科センター、その他） ・世界の爪囲炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、皮膚科センター、その他） ・北米の爪囲炎治療薬市場分析：米国、カナダ ・ヨーロッパの爪囲炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの爪囲炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の爪囲炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの爪囲炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Teva Pharmaceutical、Eli Lilly、Fougera Pharmaceuticals、Taro Pharmaceutical Industries、Glenmark Generics、Jonakayem Pharma Formulation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Paronychia usually happens when the skin around an individual’s nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to a definite abscess.
The Americas account for a major share in the global paronychia treatment market owing to the increasing prevalence of acute paronychia, chronic paronychia, candidal paronychia, and pyogenic paronychia.
Market Analysis and Insights: Global Paronychia Drugs Market
The global Paronychia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Paronychia Drugs Scope and Market Size
Paronychia Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paronychia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GlaxoSmithKline
Teva Pharmaceutical
Eli Lilly
Fougera Pharmaceuticals
Taro Pharmaceutical Industries
Glenmark Generics
Jonakayem Pharma Formulation
…
Market segment by Type, the product can be split into
Mupirocin Ointment
Fusidic Acid Ointment
Gentamicin Ointment
Dicloxacillin
Others
Market segment by Application, split into
Hospitals
Clinics
Dermatology Center
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Paronychia Drugs Revenue
1.4 Market by Type
1.4.1 Global Paronychia Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Mupirocin Ointment
1.4.3 Fusidic Acid Ointment
1.4.4 Gentamicin Ointment
1.4.5 Dicloxacillin
1.4.6 Others
1.5 Market by Application
1.5.1 Global Paronychia Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Dermatology Center
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Paronychia Drugs Market Perspective (2015-2026)
2.2 Global Paronychia Drugs Growth Trends by Regions
2.2.1 Paronychia Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Paronychia Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Paronychia Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Paronychia Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Paronychia Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Paronychia Drugs Players by Market Size
3.1.1 Global Top Paronychia Drugs Players by Revenue (2015-2020)
3.1.2 Global Paronychia Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Paronychia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Paronychia Drugs Market Concentration Ratio
3.2.1 Global Paronychia Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Paronychia Drugs Revenue in 2019
3.3 Paronychia Drugs Key Players Head office and Area Served
3.4 Key Players Paronychia Drugs Product Solution and Service
3.5 Date of Enter into Paronychia Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Paronychia Drugs Historic Market Size by Type (2015-2020)
4.2 Global Paronychia Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Paronychia Drugs Market Size by Application (2015-2020)
5.2 Global Paronychia Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Paronychia Drugs Market Size (2015-2020)
6.2 Paronychia Drugs Key Players in North America (2019-2020)
6.3 North America Paronychia Drugs Market Size by Type (2015-2020)
6.4 North America Paronychia Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Paronychia Drugs Market Size (2015-2020)
7.2 Paronychia Drugs Key Players in Europe (2019-2020)
7.3 Europe Paronychia Drugs Market Size by Type (2015-2020)
7.4 Europe Paronychia Drugs Market Size by Application (2015-2020)
8 China
8.1 China Paronychia Drugs Market Size (2015-2020)
8.2 Paronychia Drugs Key Players in China (2019-2020)
8.3 China Paronychia Drugs Market Size by Type (2015-2020)
8.4 China Paronychia Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Paronychia Drugs Market Size (2015-2020)
9.2 Paronychia Drugs Key Players in Japan (2019-2020)
9.3 Japan Paronychia Drugs Market Size by Type (2015-2020)
9.4 Japan Paronychia Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Paronychia Drugs Market Size (2015-2020)
10.2 Paronychia Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Paronychia Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Paronychia Drugs Market Size by Application (2015-2020)
11 India
11.1 India Paronychia Drugs Market Size (2015-2020)
11.2 Paronychia Drugs Key Players in India (2019-2020)
11.3 India Paronychia Drugs Market Size by Type (2015-2020)
11.4 India Paronychia Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Paronychia Drugs Market Size (2015-2020)
12.2 Paronychia Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Paronychia Drugs Market Size by Type (2015-2020)
12.4 Central & South America Paronychia Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Paronychia Drugs Introduction
13.1.4 GlaxoSmithKline Revenue in Paronychia Drugs Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Details
13.2.2 Teva Pharmaceutical Business Overview
13.2.3 Teva Pharmaceutical Paronychia Drugs Introduction
13.2.4 Teva Pharmaceutical Revenue in Paronychia Drugs Business (2015-2020)
13.2.5 Teva Pharmaceutical Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Paronychia Drugs Introduction
13.3.4 Eli Lilly Revenue in Paronychia Drugs Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Fougera Pharmaceuticals
13.4.1 Fougera Pharmaceuticals Company Details
13.4.2 Fougera Pharmaceuticals Business Overview
13.4.3 Fougera Pharmaceuticals Paronychia Drugs Introduction
13.4.4 Fougera Pharmaceuticals Revenue in Paronychia Drugs Business (2015-2020)
13.4.5 Fougera Pharmaceuticals Recent Development
13.5 Taro Pharmaceutical Industries
13.5.1 Taro Pharmaceutical Industries Company Details
13.5.2 Taro Pharmaceutical Industries Business Overview
13.5.3 Taro Pharmaceutical Industries Paronychia Drugs Introduction
13.5.4 Taro Pharmaceutical Industries Revenue in Paronychia Drugs Business (2015-2020)
13.5.5 Taro Pharmaceutical Industries Recent Development
13.6 Glenmark Generics
13.6.1 Glenmark Generics Company Details
13.6.2 Glenmark Generics Business Overview
13.6.3 Glenmark Generics Paronychia Drugs Introduction
13.6.4 Glenmark Generics Revenue in Paronychia Drugs Business (2015-2020)
13.6.5 Glenmark Generics Recent Development
13.7 Jonakayem Pharma Formulation
13.7.1 Jonakayem Pharma Formulation Company Details
13.7.2 Jonakayem Pharma Formulation Business Overview
13.7.3 Jonakayem Pharma Formulation Paronychia Drugs Introduction
13.7.4 Jonakayem Pharma Formulation Revenue in Paronychia Drugs Business (2015-2020)
13.7.5 Jonakayem Pharma Formulation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Paronychia Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Paronychia Drugs Revenue
Table 3. Ranking of Global Top Paronychia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Paronychia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Mupirocin Ointment
Table 6. Key Players of Fusidic Acid Ointment
Table 7. Key Players of Gentamicin Ointment
Table 8. Key Players of Dicloxacillin
Table 9. Key Players of Others
Table 10. Global Paronychia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Paronychia Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Paronychia Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Paronychia Drugs Market Share by Regions (2015-2020)
Table 14. Global Paronychia Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Paronychia Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Paronychia Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Paronychia Drugs Players
Table 21. Global Paronychia Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global Paronychia Drugs Market Share by Players (2015-2020)
Table 23. Global Top Paronychia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paronychia Drugs as of 2019)
Table 24. Global Paronychia Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Paronychia Drugs Product Solution and Service
Table 27. Date of Enter into Paronychia Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global Paronychia Drugs Market Size Share by Type (2015-2020)
Table 31. Global Paronychia Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global Paronychia Drugs Market Size Share by Application (2015-2020)
Table 33. Global Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global Paronychia Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players Paronychia Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Paronychia Drugs Market Share (2019-2020)
Table 37. North America Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America Paronychia Drugs Market Share by Type (2015-2020)
Table 39. North America Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America Paronychia Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players Paronychia Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Paronychia Drugs Market Share (2019-2020)
Table 43. Europe Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Paronychia Drugs Market Share by Type (2015-2020)
Table 45. Europe Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Paronychia Drugs Market Share by Application (2015-2020)
Table 47. China Key Players Paronychia Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players Paronychia Drugs Market Share (2019-2020)
Table 49. China Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China Paronychia Drugs Market Share by Type (2015-2020)
Table 51. China Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China Paronychia Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players Paronychia Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Paronychia Drugs Market Share (2019-2020)
Table 55. Japan Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Paronychia Drugs Market Share by Type (2015-2020)
Table 57. Japan Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Paronychia Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Paronychia Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Paronychia Drugs Market Share (2019-2020)
Table 61. Southeast Asia Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Paronychia Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Paronychia Drugs Market Share by Application (2015-2020)
Table 65. India Key Players Paronychia Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players Paronychia Drugs Market Share (2019-2020)
Table 67. India Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India Paronychia Drugs Market Share by Type (2015-2020)
Table 69. India Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India Paronychia Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Paronychia Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Paronychia Drugs Market Share (2019-2020)
Table 73. Central & South America Paronychia Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Paronychia Drugs Market Share by Type (2015-2020)
Table 75. Central & South America Paronychia Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Paronychia Drugs Market Share by Application (2015-2020)
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Product
Table 80. GlaxoSmithKline Revenue in Paronychia Drugs Business (2015-2020) (Million US$)
Table 81. GlaxoSmithKline Recent Development
Table 82. Teva Pharmaceutical Company Details
Table 83. Teva Pharmaceutical Business Overview
Table 84. Teva Pharmaceutical Product
Table 85. Teva Pharmaceutical Revenue in Paronychia Drugs Business (2015-2020) (Million US$)
Table 86. Teva Pharmaceutical Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Product
Table 90. Eli Lilly Revenue in Paronychia Drugs Business (2015-2020) (Million US$)
Table 91. Eli Lilly Recent Development
Table 92. Fougera Pharmaceuticals Company Details
Table 93. Fougera Pharmaceuticals Business Overview
Table 94. Fougera Pharmaceuticals Product
Table 95. Fougera Pharmaceuticals Revenue in Paronychia Drugs Business (2015-2020) (Million US$)
Table 96. Fougera Pharmaceuticals Recent Development
Table 97. Taro Pharmaceutical Industries Company Details
Table 98. Taro Pharmaceutical Industries Business Overview
Table 99. Taro Pharmaceutical Industries Product
Table 100. Taro Pharmaceutical Industries Revenue in Paronychia Drugs Business (2015-2020) (Million US$)
Table 101. Taro Pharmaceutical Industries Recent Development
Table 102. Glenmark Generics Company Details
Table 103. Glenmark Generics Business Overview
Table 104. Glenmark Generics Product
Table 105. Glenmark Generics Revenue in Paronychia Drugs Business (2015-2020) (Million US$)
Table 106. Glenmark Generics Recent Development
Table 107. Jonakayem Pharma Formulation Company Details
Table 108. Jonakayem Pharma Formulation Business Overview
Table 109. Jonakayem Pharma Formulation Product
Table 110. Jonakayem Pharma Formulation Revenue in Paronychia Drugs Business (2015-2020) (Million US$)
Table 111. Jonakayem Pharma Formulation Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paronychia Drugs Market Share by Type: 2020 VS 2026
Figure 2. Mupirocin Ointment Features
Figure 3. Fusidic Acid Ointment Features
Figure 4. Gentamicin Ointment Features
Figure 5. Dicloxacillin Features
Figure 6. Others Features
Figure 7. Global Paronychia Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Dermatology Center Case Studies
Figure 11. Others Case Studies
Figure 12. Paronychia Drugs Report Years Considered
Figure 13. Global Paronychia Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Paronychia Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Paronychia Drugs Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Paronychia Drugs Market Share by Players in 2019
Figure 18. Global Top Paronychia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paronychia Drugs as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Paronychia Drugs Revenue in 2019
Figure 20. North America Paronychia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Paronychia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Paronychia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Paronychia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Paronychia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Paronychia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Paronychia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
爪囲炎治療の世界市場（～2026年） Paronychia is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail. The infection can start suddenly (acute paronychia) or gradually (chronic paronychia). When no pus is present, warm soak…- ベビー軟膏の世界市場（～2026年） Baby ointments are usually used to prevent diaper rash, dry skin, heat rash, eczema and insect bites. The skin of the babies and the adult differ in many respects. The skin of the babies is over sensitive and there is a tendency of flaking and peeling of the skin during the first three weeks just af…
- ベタメタゾン軟膏の世界市場（～2026年） Betamethasone ointment is a steroid medication that is used to treat a number of skin diseases such as dermatitis, allergic conditions, and itching. Market Analysis and Insights: Global Betamethasone Ointment Market The global Betamethasone Ointment market size is projected to reach US$ XX million b…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- チロシンヒドロキシラーゼ欠損症治療薬の世界市場（～2026年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…